NCT06916195 Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
| NCT ID | NCT06916195 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MSD Italia S.r.l. |
| Condition | Cytomegalovirus Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 230 participants |
| Start Date | 2025-05-09 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 230 participants in total. It began in 2025-05-09 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational retrospective analysis will provide useful information for clinicians and payers, and local guidelines committee members, to improve the understanding of Cytomegalovirus clinical and economic burden and clinical management of pediatric patients undergoing allogeneic Hematopoietic Stem Cells Transplantation in Italy.
Eligibility Criteria
Inclusion Criteria: * Patients from birth to less than 18 years of age (at the moment of the allogeneic HSCT); * Patients who received allogeneic HSCT between January 2018 and June 2020; * Patients (or their legally acceptable representatives) must have signed and dated the Informed Consent \& Privacy Form (ICF), if applicable. Exclusion Criteria: * Letermovir use at any time
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06916195 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 18 Years, studying Cytomegalovirus Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06916195 currently recruiting?
Yes, NCT06916195 is actively recruiting participants. Contact the research team at info.studiclinici@opisresearch.com for enrollment information.
Where is the NCT06916195 trial being conducted?
This trial is being conducted at Genova, Italy, Monza, Italy, Padova, Italy, Roma, Italy and 1 additional location.
Who is sponsoring the NCT06916195 clinical trial?
NCT06916195 is sponsored by MSD Italia S.r.l.. The trial plans to enroll 230 participants.